Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05061238 · ClinicalTrials.gov registry record · NA

Impact Of Muscle Vibration On Gait Control

A NA study of Muscle, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT05061238 is a NA study of Muscle that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05061238, a NA study of Muscle, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This is a single-site interventional open label pilot study of a non-significant risk medical device on patients with defined peripheral neuropathy secondary to chemotherapy (N=10). Patients who have received chemotherapy and have evidence of neuropathy will be seen at MD Anderson. Their severity of neuropathy will be documented and assessed by physical therapy, occupational therapy and based on self-reported activities of daily living (ADL) impairment.

Conditions Studied

Interventions

  • DEVICE Vibrating Device

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-10-04
Est. Completion 2027-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05061238

The ClinicalTrials.gov registry entry for NCT05061238 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Muscle appearing as the primary indexed condition, and to 1 intervention - of which Vibrating Device is the first listed.

NCT05061238 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05061238 about?

NCT05061238 is a clinical study titled "Impact Of Muscle Vibration On Gait Control". This is a single-site interventional open label pilot study of a non-significant risk medical device on patients with defined peripheral neuropathy secondary to chemotherapy (N=10). Patients who have received chemotherapy and have evidence of neuropathy will be seen at MD Anderson. Their severity of...

What is the current status of trial NCT05061238?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2021-10-04. Estimated completion is 2027-12-31.

What conditions does trial NCT05061238 study?

This clinical trial studies the following conditions: Muscle.

What interventions are being tested in trial NCT05061238?

The interventions under investigation include: Vibrating Device (DEVICE).

Who is sponsoring clinical trial NCT05061238?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05061238 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Muscle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.